DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 203867
The generic ingredient in TELMISARTAN is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
Summary for 203867
Tradename: | TELMISARTAN |
Applicant: | Sandoz Inc |
Ingredient: | telmisartan |
Patents: | 0 |
Therapeutic Class: | Cardiovascular Agents |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203867
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Suppliers and Packaging for NDA: 203867
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TELMISARTAN | telmisartan | TABLET;ORAL | 203867 | ANDA | Sandoz Inc | 0781-5372 | N | 0781-5372-64 |
TELMISARTAN | telmisartan | TABLET;ORAL | 203867 | ANDA | Sandoz Inc | 0781-5372 | N | 0781-5372-06 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Nov 3, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Nov 3, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Nov 3, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription